Cargando…
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
The rapid advancement of genome editing technologies has opened up new possibilities in the field of medicine. Nuclease-based techniques such as the CRISPR/Cas9 system are now used to target genetically linked disorders that were previously hard-to-treat. The CRISPR/Cas9 gene editing approach wields...
Autores principales: | Han, Hua Alexander, Pang, Jeremy Kah Sheng, Soh, Boon-Seng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220873/ https://www.ncbi.nlm.nih.gov/pubmed/32198625 http://dx.doi.org/10.1007/s00109-020-01893-z |
Ejemplares similares
-
Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023) -
Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015) -
Spatial control of in vivo CRISPR–Cas9 genome editing via nanomagnets
por: Zhu, Haibao, et al.
Publicado: (2018) -
In Vivo CRISPR/Cas9-Mediated Genome Editing Mitigates Photoreceptor Degeneration in a Mouse Model of X-Linked Retinitis Pigmentosa
por: Hu, Shuang, et al.
Publicado: (2020) -
Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing
por: Denes, Christopher E., et al.
Publicado: (2021)